Journey Medical (DERM) Free Cash Flow Growth (3y) (2023 - 2026)
Journey Medical (DERM) Free Cash Flow Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 90.13 Bn | 88.27 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.98 Bn | 32.24 Bn | 1.97 Bn | 9.86% |
| 3 | Zoetis | 32.59 Bn | 30.65 Bn | 1.62 Bn | -18.92% |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn | -44.64% |
| 5 | United Therapeutics | 23.08 Bn | 20.93 Bn | 648.10 Mn | 0.68% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.38 Bn | 18.57 Bn | 1.16 Bn | -27.74% |
| 8 | Neurocrine Biosciences | 17.80 Bn | 16.48 Bn | 800.70 Mn | 46.56% |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | 39.19% |
| 10 | Journey Medical | 171.89 Mn | 144.67 Mn | 9.70 Mn | 35.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.51% |
| Dec 31, 2025 | -17.88% |
| Sep 30, 2025 | 31.09% |
| Jun 30, 2025 | 34.16% |
| Mar 31, 2025 | 47.09% |
| Dec 31, 2024 | 39.14% |
| Sep 30, 2024 | -29.32% |
| Jun 30, 2024 | 11.38% |
| Mar 31, 2024 | -78.50% |
| Dec 31, 2023 | -172.23% |